中国实用儿科杂志
• 专题笔谈 • 上一篇 下一篇
出版日期:
发布日期:
Online:
Published:
摘要:
脓毒症是危重症领域的重大难题。脓毒症致死的重要原因之一就是凝血功能紊乱,尤其是并发弥散性血管内凝血(DIC)时病死率大大增加。凝血功能障碍始终贯穿于脓毒症的病理过程,其出现及转归是影响患者临床转归的重要且独立的预测因素。凝血系统的激活和炎性反应相互促进,生理性抗凝系统及纤溶系统的抑制是脓毒症凝血功能障碍的病理生理基础。因此,脓毒症的抗凝治疗具备充足的理论基础。然而,目前对于脓毒症的抗凝治疗仍未有一致定论。文章对脓毒症的凝血功能障碍的机制,抗凝治疗的研究进展进行了探讨。
关键词: 脓毒症, 凝血功能障碍, 抗凝治疗, 微血栓形成, 弥散性血管内凝血
Abstract:
Sepsis is a major problem in the field of critical illness. One of the important reasons for the death of sepsis is the disorder of coagulation function,especially in the case of DIC. Coagulation dysfunction is always in the pathological process of sepsis,and its occurrence and prognosis is an important and independent prognostic factor. The activation of coagulation system and inflammatory response promote each other,and the inhibition of physiological anticoagulant system and fibrinolysis system are the pathophysiological basises of coagulation dysfunction in sepsis. Therefore,the anticoagulant therapy of sepsis has sufficient theoretical basis. However,there is no consistent conclusion about the treatment of sepsis at present. This article will discuss the mechanism of coagulation dysfunction and the research progress of anticoagulation therapy.
Key words: sepsis, coagulopathy, anticoagulant therapy, thrombosis, disseminated intravascular coagulation
祝益民,吴 琼. 脓毒症与抗凝治疗[J]. 中国实用儿科杂志, DOI: 10.19538/j.ek2017060611.
ZHU Yi-min,WU Qiong. Sepsis and anticoagulant therapy[J]. CJPP, DOI: 10.19538/j.ek2017060611.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.zgsyz.com/zgsyek/CN/10.19538/j.ek2017060611
http://www.zgsyz.com/zgsyek/CN/Y2017/V32/I6/443